Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
28.72
+1.08 (3.91%)
At close: Mar 27, 2026
| Market Cap | 3.91B |
| Revenue (ttm) | 2.34M -13.4% |
| Net Income | -123.26M |
| EPS | -11.28 |
| Shares Out | 136.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 131,100 |
| Average Volume | 188,445 |
| Open | 27.34 |
| Previous Close | 27.64 |
| Day's Range | 26.76 - 29.00 |
| 52-Week Range | 13.48 - 32.00 |
| Beta | 0.84 |
| RSI | 78.67 |
| Earnings Date | Mar 27, 2026 |